Skip to main content

Advertisement

Log in

The effects of intraperitoneal metoprolol administration on healing of bone defects in rat tibia: a pilot study

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

Metoprolol is a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties, devoid of intrinsic sympathomimetic activity. Various studies have suggested the effect of beta-blockers on bone remodeling. We aimed to investigate whether metoprolol affects bone remodeling by altering anti-inflammatory and pro-inflammatory cytokines.

Materials and methods

Surgical defects of 3 mm diameter were created in tibiae of 72 Sprague-Dawley rats. Rats were randomly assigned to a control group without metoprolol treatment (n = 36), and a test group treated with 0.1 mg/kg/day metoprolol (n = 36). Six rats from each group were sacrificed at days 0, 1, 3, 5, 7, and 14. The percentages of cells, which showed positive immunohistochemical staining for IL-1β, IL-6, IL-10, and RANKL, were assessed in the defect area. Differences in percentages of stained cells within each of the test and control groups over various time intervals were tested using one-way ANOVA test. A P value of < 0.05 was considered statistically significant.

Results

No significant differences in IL-1β, IL-10, IL-6, and RANKL expressions were found between test and control groups at the same interval. Significant reduction was observed at different time intervals in the same group (P < 0.05).

Conclusion

Metoprolol did not reduce bone-active cytokine: IL-1β, IL-6, and RANKL. It also did not elevate IL-10 expression levels. Thus, it does not appear to decrease osteoclastogenesis.

Clinical relevance

Results from this animal model help us understand any effect of metoprolol on bone healing by potential contribution to different real-world clinical research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Gerstenfeld L, Cullinane D, Barnes G, Graves D, Einhorn T (2003) Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:873–884

    Article  Google Scholar 

  2. Einhorn T, Majeska RJ, Rush E, Levine P, Horowitz M (1995) The expression of cytokine activity by fracture callus. J Bone Miner Res 10(8):1272–1281

    Article  Google Scholar 

  3. Harada SI, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423(6937):349

    Article  Google Scholar 

  4. Hernández-Cortés P, Monje A, Galindo-Moreno P, Catena A, Ortega-Oller I, Salas-Pérez J, Mesa F, Gómez-Sánchez R, Aguilar M, Aguilar D, O’Valle F (2014) An ex vivo model in human femoral heads for histopathological study and resonance frequency analysis of dental implant primary stability. BioMed Res Int 2014

  5. Tarantino U, Cerocchi I, Celi M, Scialdoni A, Saturnino L, Gasbarra E (2009) Pharmacological agents and bone healing. Clin Cases Miner Bone Metab 6(2):144

    PubMed  PubMed Central  Google Scholar 

  6. Bukata S (2011) Systemic administration of pharmacological agents and bone repair: what can we expect. Injury. 42(6):605–608

    Article  Google Scholar 

  7. Frishman WH, Saunders E (2011) β-Adrenergic blockers. J Clin Hypertens 13(9):649–653

    Article  Google Scholar 

  8. Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, et al. (2007). Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, Benhamou CL. Protective effect of β blockers in post- menopausal women: influence on fractures, bone density, micro and macroarchitecture. p 1209–1216

  9. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker K et al (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell. 111(2):305–317

    Article  Google Scholar 

  10. Bonnet N, Benhamou C, Malaval L, Goncalves C, Vico L, Eder V et al (2008) Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol 217(3):819–827 cellular physiology. 2008 Dec;217(3):819–27

    Article  Google Scholar 

  11. Sadr K, Aghbali A, Sadr M, Abachizadeh H, Azizi M, Abbasi M (2017) Effect of Beta-blockers on number of osteoblasts and osteoclasts in alveolar socket following tooth extraction in Wistar rats. J Dent 18(1):37

    Google Scholar 

  12. Bologna-Molina R, Damián-Matsumura P (2011) An easy cell counting method for immunohistochemistry that does not use an image analysis program. Histopathology. 217(3):801–803

    Article  Google Scholar 

  13. O’loughlin P, Morr S, Bogunovic L, Kim AD, Park B, Lane JM (2008) Selection and development of preclinical models in fracture-healing research. JBJS 90:79–84 JBJS. 2008 Feb 1;90:79–84

    Article  Google Scholar 

  14. Guehennec LL, Goyenvalle E, Aguado E, Houchmand-Cuny M, Enkel B, Pilet P et al (2005) Small-animal models for testing macroporous ceramic bone substitutes. J Biomed Mater Res B Appl Biomater Offi J Soc Biomater Jpn Soc Biomater Aust Soc Biomater Korean Soc Biomater 72(1):69–78

    Google Scholar 

  15. Schmitz J, Hollinger J (1986) The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 205:205–299

    Google Scholar 

  16. Rodrigues W, Madeira M, Silva TD, Clemente-Napimoga J, Miguel CB, da Silva VJD et al (2012) Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. Br J Pharmacol 165(7):165–167

    Article  Google Scholar 

  17. Group BDW, Jr AA, Colburn WA, DeGruttola VG, DeMets DL, Downing G et al (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95

    Article  Google Scholar 

  18. Han D, Han N, Xue F, Zhang P (2015) A novel specialized staging system for cancellous fracture healing, distinct from traditional healing pattern of diaphysis cortical fracture. Int J Clin Exp Med 8(1):1301

    PubMed  PubMed Central  Google Scholar 

  19. Inoue S, Otsuka H, Takito J, Nakamura M (2018) Decisive differences in the bone repair processes of the metaphysis and diaphysis in young mice. Bone Reports 8:1–8

    Article  Google Scholar 

  20. Iizuka T, Miller SC, Jr SM (1992) Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats. J Oral Pathol Med 21(4):150–155

    Article  Google Scholar 

  21. Devlin H, Hoyland J, Newall JF, Ayad S (1997) Trabecular bone forma- tion in the healing of the rodent molar tooth extraction socket. J Bone Miner Res 12(12):2061–2067 12(12):2061–7

    Article  Google Scholar 

  22. Vieira A, Repeke CE, Junior SD, Colavite PM, Biguestti CC, Oliveria R et al (2015) Intramembranous bone healing process subsequent to tooth extraction in mice: micro-computed tomography, histomorphometric and molecular characterization. PLoS One 10(5):e0128021

    Article  Google Scholar 

  23. Sabatini M, Aufdemorte T, Bonewald L, Mundy G (1988) Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci 85(14):5235–5239

    Article  Google Scholar 

  24. Roodman G (1992) Perspectives: interleukin-6: an osteotropic factor? J Bone Miner Res 7(5):475–478

    Article  Google Scholar 

  25. Konda A, Mogi M, Koshihara Y, Togari A (2001) Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochemical pharmacology. Biochem Pharmacol 61(3):319–326

    Article  Google Scholar 

  26. Tera T, Prado RF, de Marco A, Santamaria MP, Jardini MA (2014) The RANK/RANKL/OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. Braz Oral Res 28(1):1–9

    Article  Google Scholar 

  27. Levasseur R, Dargent-Molina P, Sabatier JP, Marcelli C, Bréart G (2005) Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l’Osteoporose prospective study. J Am Geriatr Soc 53(3):550–552

    Article  Google Scholar 

  28. Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC (2005) β-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 20(4):613–618

    Article  Google Scholar 

  29. Khosla S, Volkman TL, Thicke BS, Achenbach SJ, Atkinson EJ, Joyner MJ, et al. (2018). Sympathetic β 1-adrenergic signaling contributes to regulation of human bone metabolism. J Clin 128(11)

  30. Zang Y, Tan Q, Ma X, Zhao X, Lei W (2016) Osteogenic actions of metoprolol in an ovariectomized rat model of menopause. Menopause. 23(9):1019–1025

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge Rayan Arfawi, Anas Aldowaji, Tayeb Kanaan, and Bashar Obeid for their assistance in this study.

Funding

This study was fully funded by the Deanship of Scientific Research, Jordan University of Science and Technology (JUST). Number 20170375

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Al Alawy.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval and consent to participate

The study was independently reviewed and approved by the Institutional Research Board (IRB) of Jordan University of Science and Technology (JUST).

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al Alawy, R., Hammad, H. & AlHabashneh, R. The effects of intraperitoneal metoprolol administration on healing of bone defects in rat tibia: a pilot study. Clin Oral Invest 24, 1239–1247 (2020). https://doi.org/10.1007/s00784-019-02987-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-019-02987-w

Keywords

Navigation